Literature DB >> 12225999

Family history of cancer and incidence of acute leukemia in adults.

Garth H Rauscher1, Dale P Sandler, Charles Poole, James Pankow, Beverly Mitchell, Clara D Bloomfield, Andrew F Olshan.   

Abstract

Family history of cancer may represent shared genetic and environmental risk factors for leukemia. The authors examined associations of first-degree family history of cancer with adult acute leukemia incidence by using data on 811 patients (or their proxies) identified at diagnosis and 637 population-based controls in the United States and Canada during 1986-1990. For proxy-interviewed patients, relative risks were elevated for family history of any cancer (relative risk = 1.7, 95% confidence interval (CI): 1.3, 2.4), hematopoietic cancer (relative risk = 1.8, 95% CI: 1.1, 3.0), leukemia (relative risk = 2.4, 95% CI: 1.3, 4.6), and breast cancer (relative risk = 1.7, 95% CI: 1.0, 3.0) but not for colorectal, prostate, or lung cancer. For self-interviewed patients, family history of hematopoietic cancer was inversely associated with leukemia incidence (relative risk = 0.6, 95% CI: 0.4, 1.1). Regardless of patient interview type, history of breast cancer in sisters was positively associated with adult acute leukemia, whereas history of breast cancer in mothers was not. The role of family history of cancer in leukemia etiology is unclear because of differential reporting by patients and proxies. Specifically, self-interviewed patients may underreport cancer in their first-degree relatives. Associations between family history of breast cancer and leukemia incidence may be the result of unmeasured, shared etiologies specific to these cancers.

Entities:  

Mesh:

Year:  2002        PMID: 12225999     DOI: 10.1093/aje/kwf075

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Aberrant phenotype in Iranian patients with acute myeloid leukemia.

Authors:  Mehdi Jahedi; Karim Shamsasenjan; Zohreh Sanaat; Mohammadreza Aliparasti; Shohreh Almasi; Mozhdeh Mohamadian; Babak Nejati; Amir Kamalifar; Ali Akbar Movassaghpour
Journal:  Adv Pharm Bull       Date:  2013-12-23

2.  Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study.

Authors:  Briseis A Kilfoy; Yawei Zhang; Xiao-Ou Shu; Yu-Tang Gao; Bu-Tian Ji; Gong Yang; Hong Lan Li; Nathaniel Rothman; Wong-Ho Chow; Wei Zheng
Journal:  Cancer Causes Control       Date:  2008-06-25       Impact factor: 2.506

3.  Measures for the degree of overlap of gene signatures and applications to TCGA.

Authors:  Xingjie Shi; Huangdi Yi; Shuangge Ma
Journal:  Brief Bioinform       Date:  2014-12-31       Impact factor: 13.994

4.  Long-term safety of filgrastim (rhG-CSF) administration.

Authors:  Dennis L Confer; John P Miller
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

5.  Multiple primary tumours in women following breast cancer, 1973-2000.

Authors:  J S Raymond; C J R Hogue
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

6.  Family history and prior allergies of cancers and the risk of adult leukemia in shandong province, china.

Authors:  H C Wang; H L Lin; N Shao; J R Zhang; J Zou; C Y Ji
Journal:  Iran J Public Health       Date:  2012-01-31       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.